BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21439034)

  • 1. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).
    Masocco M; Kodra Y; Vichi M; Conti S; Kanieff M; Pace M; Frova L; Taruscio D
    Orphanet J Rare Dis; 2011 Mar; 6():11. PubMed ID: 21439034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
    Rasmussen SA; Yang Q; Friedman JM
    Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
    Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
    Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.
    Vidal-Millan S; Zatarain-Barrón ZL; Daza-Galicia K; Shveid Gerson D; Pichardo-Rojas PS; Salazar-Pigeon A; Wegman-Ostrosky T
    Front Oncol; 2023; 13():1291286. PubMed ID: 38260834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved renal function in neurofibromatosis type 1 patients.
    Yasuda KI; Nobeyama Y; Asahina A
    Skin Health Dis; 2022 Jun; 2(2):e119. PubMed ID: 35677927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors.
    Rabab'h O; Gharaibeh A; Al-Ramadan A; Ismail M; Shah J
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital.
    Nishida Y; Ikuta K; Natsume A; Ishihara N; Morikawa M; Kidokoro H; Muramatsu Y; Nonobe N; Ishizuka K; Takeichi T; Kanbe M; Mizuno S; Imagama S; Ozaki N
    Sci Rep; 2021 Jun; 11(1):11933. PubMed ID: 34099792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Case of Retroperitoneal Plexiform Neurofibromas Found in a Trauma Patient.
    Mao A; Rana HN; Elramah M; Martin B
    Cureus; 2021 Jan; 13(1):e12997. PubMed ID: 33659131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment, Resource Use and Costs Among Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibromas.
    Yang X; Desai K; Agrawal N; Mirchandani K; Chatterjee S; Sarpong E; Sen S
    Pediatric Health Med Ther; 2020; 11():421-428. PubMed ID: 33117057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. After
    Fletcher JS; Pundavela J; Ratner N
    Neurooncol Adv; 2020 Jul; 2(Suppl 1):i23-i32. PubMed ID: 32642730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploinsufficiency of the
    Kallionpää RA; Peltonen S; Leppävirta J; Pöyhönen M; Auranen K; Järveläinen H; Peltonen J
    J Med Genet; 2021 Jun; 58(6):378-384. PubMed ID: 32571896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Combination of Metachronous Primary Malignancies of the Thyroid and Breast in a Patient with Neurofibromatosis Type 1.
    Findakly D; Solsi A; Arslan W
    Cureus; 2020 Apr; 12(4):e7590. PubMed ID: 32399324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis Type 1 with the Development of Pheochromocytoma and Breast Cancer.
    Lee YH; Kwon MJ; Park JH; Jeong SJ; Kim TH; Jeong HW; Lee SH
    Intern Med; 2020 Jul; 59(13):1665-1669. PubMed ID: 32269189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.
    Suarez-Kelly LP; Yu L; Kline D; Schneider EB; Agnese DM; Carson WE
    Hered Cancer Clin Pract; 2019; 17():12. PubMed ID: 30962859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic, Clinical and Histopathological Features of Oral Neural Neoplasms: A Retrospective Study.
    Alotaiby FM; Fitzpatrick S; Upadhyaya J; Islam MN; Cohen D; Bhattacharyya I
    Head Neck Pathol; 2019 Jun; 13(2):208-214. PubMed ID: 29931661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased insulin sensitivity in individuals with neurofibromatosis type 1.
    Martins AS; Jansen AK; Rodrigues LOC; Matos CM; Souza MLR; Miranda DM; Rezende NA
    Arch Endocrinol Metab; 2018 Feb; 62(1):41-46. PubMed ID: 29694637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis.
    Lee Y; Tan LYR; Ho YH; Leow MKS
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29102976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Florid cemento-osseous dysplasia and peripheral giant cell granuloma in a patient with neurofibromatosis 1.
    Sarmento DJS; Carvalho SHG; Araújo JCWP; Carvalho MV; Silveira ÉJDD
    An Bras Dermatol; 2017; 92(2):249-252. PubMed ID: 28538890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower fasting blood glucose in neurofibromatosis type 1.
    Martins AS; Jansen AK; Rodrigues LO; Matos CM; Souza ML; de Souza JF; Diniz Mde F; Barreto SM; Diniz LM; de Rezende NA; Riccardi VM
    Endocr Connect; 2016 Jan; 5(1):28-33. PubMed ID: 26631381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumor of the colon in a patient with von Recklinghausen's disease: report of a case.
    Marwah S; Gurawalia JP; Sheoran KD; Marwah N; Gupta S; Ranga H
    Clin J Gastroenterol; 2013 Dec; 6(6):429-33. PubMed ID: 26182132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.